Squarepoint
CSBR icon

Squarepoint’s Champions Oncology CSBR Stock Holding History

Squarepoint’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,409
Closed -$152K – 2970
2020
Q3 		$152K Buy
+16,409
New +$146K ﹤0.01% 2187
2019
Q1 		– Sell
-23,659
Closed -$185K – 2184
2018
Q4 		$185K Buy
+23,659
New +$272K ﹤0.01% 1708

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's CSBR Position: Q4 2020 in Review

Squarepoint sold out of Champions Oncology (CSBR) in Q4 2020, closing a stake of 16,409 shares — an estimated $152K sold.

Squarepoint first reported a position in CSBR in Q4 2018 and held it in 2 quarters. The position peaked at $185K in Q4 2018. 47 funds tracked by Wall St. Rank hold CSBR as of Q4 2020.

  • Squarepoint reported no remaining Champions Oncology position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 16,409 Champions Oncology shares in Q4 2020, an estimated $152K.
  • Squarepoint first reported a position in Champions Oncology in Q4 2018 and held it in 2 quarters.
  • Squarepoint's Champions Oncology position peaked at $185K in Q4 2018.
  • 47 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.